These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11141631)

  • 21. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on ocular complications of systemic cancer chemotherapy.
    Schmid KE; Kornek GV; Scheithauer W; Binder S
    Surv Ophthalmol; 2006; 51(1):19-40. PubMed ID: 16414359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
    Bowman RJ; Cope J; Nischal KK
    Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics.
    Kunkler AL; Binkley EM; Mantopoulos D; Hendershot AJ; Ohr MP; Kendra KL; Davidorf FH; Cebulla CM
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1771-1781. PubMed ID: 31098752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caution in prescribing antidepressants for patients with cancer.
    Xu F
    Am J Health Syst Pharm; 2008 Apr; 65(8):700. PubMed ID: 18387895
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse drug reactions in the nervous system.
    Spector R; Goldberg MJ
    J Iowa Med Soc; 1983 Apr; 73(4):144-7. PubMed ID: 6854079
    [No Abstract]   [Full Text] [Related]  

  • 27. Ocular complications of systemic cancer chemotherapy.
    Imperia PS; Lazarus HM; Lass JH
    Surv Ophthalmol; 1989; 34(3):209-30. PubMed ID: 2694416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular side effects of cancer chemotherapy.
    Vizel M; Oster MW
    Cancer; 1982 May; 49(10):1999-2002. PubMed ID: 7074524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
    Agustoni F; Platania M; Vitali M; Zilembo N; Haspinger E; Sinno V; Gallucci R; de Braud F; Garassino MC
    Cancer Treat Rev; 2014 Feb; 40(1):197-203. PubMed ID: 23850197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular toxicity associated with systemic drug therapy.
    Moorthy RS; Valluri S
    Curr Opin Ophthalmol; 1999 Dec; 10(6):438-46. PubMed ID: 10662249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ophthalmic complications of targeted cancer therapy and recently recognized ophthalmic complications of traditional chemotherapy.
    Kheir WJ; Sniegowski MC; El-Sawy T; Li A; Esmaeli B
    Surv Ophthalmol; 2014; 59(5):493-502. PubMed ID: 25130892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse effects of medications commonly used in the treatment of migraine.
    Whyte CA; Tepper SJ
    Expert Rev Neurother; 2009 Sep; 9(9):1379-91. PubMed ID: 19769452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ocular surface injury resulted from topical anti-glaucoma medications: prevention and cure].
    Ouyang PB; Duan XC
    Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):557-61. PubMed ID: 22943813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral drug-induced ocular pseudopemphigoid.
    Gibran SK
    Eye (Lond); 2004 Dec; 18(12):1270. PubMed ID: 15044940
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk factors to develop ocular surface disease 
in treated glaucoma or ocular hypertension patients.
    Rossi GC; Pasinetti GM; Scudeller L; Raimondi M; Lanteri S; Bianchi PE
    Eur J Ophthalmol; 2013; 23(3):296-302. PubMed ID: 23335308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular manifestations of neurological disease.
    O'Sullivan EP; Kennard C
    Curr Opin Neurol; 1998 Feb; 11(1):25-9. PubMed ID: 9484613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic management of glaucoma in childhood.
    Moore W; Nischal KK
    Paediatr Drugs; 2007; 9(2):71-9. PubMed ID: 17407363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of medications on the eyes].
    Labetoulle M; Pogorzalek N; Offret H; Le Jeunne C
    Rev Prat; 2006 Jun; 56(11):1203-13. PubMed ID: 16903521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications.
    Saini M; Dhiman R; Dada T; Tandon R; Vanathi M
    Eye (Lond); 2015 Jun; 29(6):808-14. PubMed ID: 25857609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.